Welcome to our dedicated page for Assertio Holdings SEC filings (Ticker: ASRT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Assertio Holdings, Inc. filings document formal disclosures for a Nasdaq-listed commercial pharmaceutical company, including material-event reports, annual meeting voting results, governance actions, and capital-structure matters. The record includes disclosures on common stock, convertible senior notes, tender-offer communications, and amendments to equity incentive plan provisions.
Assertio's SEC reports also cover material definitive agreements and completed asset-sale disclosures involving branded products such as INDOCIN, SPRIX, SYMPAZAN, CAMBIA, ZIPSOR, and OTREXUP. These filings describe transaction documents, Regulation FD communications, shareholder approvals, executive-compensation plan matters, and operating subjects tied to the company's pharmaceutical commercialization business.
Assertio Holdings, Inc. director Sravan Kumar Emany reported that all of his equity in the company was cashed out in connection with Assertio’s merger with Zydus Worldwide DMCC. On June 16, 2026, 23,855 shares of common stock were disposed of pursuant to the tender offer at the cash Offer Price of $23.50 per share. In addition, stock options covering 5,415, 5,415 and 1,753 shares of common stock, with exercise prices of $9.2565, $15.1500 and $16.0500 respectively, were cancelled and converted into cash rights under the merger agreement. Following these transactions, the filing shows Emany with zero reported direct holdings of Assertio common stock or related options.
Assertio Holdings, Inc. President and COO Paul Schwichtenberg reported dispositions of his equity awards in connection with Assertio’s merger with Zydus entities. A tender offer for all Assertio common shares closed at an Offer Price of $23.50 per share in cash, followed by a merger making Assertio a wholly owned subsidiary.
Schwichtenberg disposed of 13,987 shares of common stock and multiple stock option grants and restricted stock units that were cancelled at the merger’s effective time. Unvested restricted stock units became fully vested and were converted into the right to receive cash at $23.50 per share, and in-the-money stock options were cancelled for a cash payment based on the spread between the offer price and each option’s exercise price. Out-of-the-money options were cancelled without payment, and his reported positions in these awards fell to zero.
Assertio Holdings, Inc. CEO Mark L. Reisenauer reported the disposition of all his reported equity interests in connection with Assertio’s cash merger with an affiliate of Zydus. A tender offer acquired all outstanding Assertio common shares at $23.50 per share in cash, after which the merger closed.
The filing shows 3,583 common shares cancelled and converted into the right to receive cash. In addition, 33,333 restricted stock units became fully vested immediately before the merger and were then cancelled for a cash payment per unit equal to the $23.50 offer price.
Stock options with exercise prices below the offer price, including 26,667 options at $11.77, 66,666 options at $12.372, and 5,415 options at $12.7515, were cancelled and converted into cash equal to the spread between $23.50 and the respective exercise prices, multiplied by the optioned shares. Options with exercise prices at or above $23.50 were cancelled without payment. Following these transactions, the Form 4 reports zero common shares, stock options, or RSUs remaining for the CEO.
Assertio Holdings director Heather L. Mason reported the cash-out of her equity in connection with Assertio’s merger with Zydus entities. The filing shows that all of her common shares were disposed of pursuant to a tender offer completed at $23.50 per share in cash.
The transactions include 6,666 common shares held indirectly through a trust and 20,944 shares held directly, all converted into the right to receive the cash offer price at the merger’s effective time on June 16, 2026. In addition, stock options covering 5,415 shares at a $9.2565 exercise price and 36,666 shares at a $17.10 exercise price were cancelled and converted into cash based on the offer price, while options with exercise prices at or above the offer price received no payment. Following these steps, the Form 4 shows Mason with no remaining Assertio common shares or stock options.
Assertio Holdings, Inc. director David Matthew Stark disposed of his equity in connection with the company’s merger. A tender offer by Zydus Worldwide DMCC paid $23.50 in cash per share for all outstanding Assertio common stock. Stark’s 11,420 shares of common stock were cancelled and converted into the right to receive this cash amount per share.
Two blocks of stock options covering 5,415 shares at a $9.2565 exercise price and 5,415 shares at a $15.15 exercise price were also cancelled and converted into cash based on the merger formula. Following these transactions, Stark reported zero shares and zero options remaining.
Assertio Holdings, Inc. executive vice president and CFO Ajay Patel reported the cancellation of all his equity in connection with Assertio’s cash merger with Zydus entities. The merger followed a tender offer for all Assertio common shares at $23.50 per share in cash.
Patel disposed of 15,942 shares of common stock and multiple equity awards. Stock options covering 21,128 shares at $11.77, 12,591 shares at $12.177, 22,666 shares at $11.8965, and 15,666 shares at $19.65, as well as 26,026 restricted stock units, were cancelled and converted into rights to receive cash based on the Offer Price, subject to withholding taxes. Options with exercise prices at or above $23.50 received no payment. Following these transactions, the filing shows Patel with no remaining Assertio shares or derivative awards.
Assertio Holdings, Inc. files post-effective amendments to deregister all unissued and unsold securities under two Form S-3 registration statements after completing a merger with Zydus Worldwide DMCC. The registrant states the Offer expired June 15, 2026, Purchaser accepted tendered shares on June 16, 2026, and the Merger closed the same day.
The amendments remove from registration the remaining securities tied to Registration Statement No. 333-277831 (up to $150,000,000) and Registration Statement No. 333-252368 (up to $100,000,000) and terminate the effectiveness of those filings.
Assertio Holdings, Inc. filed post-effective amendments to deregister all unissued and unsold securities under two Form S-3 registration statements—one covering up to $150,000,000 aggregate offering price and the other up to $100,000,000. The company entered into a Merger Agreement on May 13, 2026; a tender offer began May 18, 2026 at $23.50 per share, expired after 11:59 p.m. ET on June 15, 2026, and Purchaser accepted shares for payment on June 16, 2026. On June 16, 2026 the Purchaser merged into the company under Section 251(h) of Delaware law, leaving the registrant as a wholly owned subsidiary of Parent and terminating the effectiveness of the Registration Statements.
Assertio Holdings, Inc. files post-effective amendments to deregister securities under two Form S-4 registration statements after completing a merger. The S-4s previously registered up to 45,449,280 shares and 43,860,220 shares, respectively, related to prior merger transactions. Pursuant to an Agreement and Plan of Merger entered on May 13, 2026, Purchaser commenced a tender offer on May 18, 2026 at $23.50 per share. The Offer expired on June 15, 2026, Purchaser accepted tendered shares on June 16, 2026, and the Purchaser merged with and into Assertio on June 16, 2026, making Assertio a wholly-owned subsidiary. The registrant states it has terminated the registered offerings and is removing from registration any unsold securities by these post-effective amendments.
Assertio Holdings, Inc. files post-effective amendments to deregister securities previously registered on Form S-4 following a completed merger.
Under a Merger Agreement dated May 13, 2026, Purchaser acquired outstanding shares at $23.50 per share, and on June 16, 2026 the Registrant merged into Purchaser and became a wholly-owned subsidiary, after which Assertio terminated the registered offerings and removed any unsold shares from the registration statements.